Lantern Pharma Inc.

Q2 2023 13F Holders

Symbol
LTRN
CUSIP
51654W101
Type
Equity
Class
COM
Num filings
28
Total reported value, excl. options
$6.50 M
Manager Report Date Value ($000) Shares Option Type